|
2023
|
Invention
|
Modified red blood cell and use thereof for delivering medicament. Provided is a modified red blo... |
|
2022
|
Invention
|
Cells modified by conjugated n-terminal glycine and uses thereof. Provided is a cell having an ag... |
|
|
Invention
|
Neoantigenic peptide and its use for treating braf gene mutation related diseases. The present di... |
|
|
Invention
|
Modified red blood cells and uses thereof for treating hyperuricemia and gout.
Provided are a re... |
|
|
Invention
|
Modified red blood cells and uses thereof for treating hyperuricemia and gout. Provided are a red... |
|
2021
|
Invention
|
Modified red blood cells and uses thereof for delivering agents.
Provided is a method for covale... |
|
|
Invention
|
Modified red blood cells and uses thereof for delivering agents. Provided is a method for covalen... |
|
|
Invention
|
Methods for preparing mature red blood cells in vitro. Provided is a method for producing red blo... |
|
|
Invention
|
Modified red blood cells and uses thereof for delivering agents.
A red blood cell (RBC) having a... |
|
|
Invention
|
Novel truncated sortase variants. Provided are novel truncated sortase variants. Specifically, pr... |
|
|
Invention
|
Modified red blood cells and uses thereof for delivering agents. A red blood cell (RBC) having an... |
|
2020
|
Invention
|
Engineering red blood cells for treating gout and hyperuricemia diseases. Provided are engineered... |
|
|
Invention
|
Engineering red blood cells for treatment of lysosomal storage diseases. Provided is a method of ... |
|
|
Invention
|
Engineered red blood cells presenting specific cancer neoantigen with artificial mhc. Provided he... |
|
|
Invention
|
Method for preparing mature red blood cells in vitro using peripheral blood.
The present disclos... |
|
|
Invention
|
In vitro using peripheral blood. The present disclosure provides a method for producing red blood... |
|
2019
|
Invention
|
Genetically engineered erythrocytes carrying anti-pd-1 single chain antibody and preparation meth... |
